The Association between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of Upadacitinib

被引：0
|
作者：
Strand, Vibeke [1 ]
Damjanov, Nemanja [2 ]
Scoville, Craig [3 ]
Tundia, Namita [4 ]
Camp, Heidi S. [4 ]
Chen, Kun [4 ]
Suboticki, Jessica [4 ]
van Vollenhoven, Ronald [5 ]
机构：
[1] Stanford Univ, Div Immunol Rheumatol, Palo Alto, CA 94304 USA
[2] Univ Belgrade, Inst Rheumatol, Sch Med, Belgrade, Serbia
[3] Idaho Falls Arthrit Clin, Idaho Falls, ID USA
[4] AbbVie Inc, N Chicago, IL USA
[5] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2546
引用
收藏
页数：2
相关论文
共 50 条
  • [1] THE ASSOCIATION BETWEEN PATIENT REPORTED OUTCOMES AND CLINICAL MEASURES AMONG RHEUMATOID ARTHRITIS PATIENTS: ANALYSES USING PHASE 3 CLINICAL TRIALS OF UPADACITINIB
    Strand, Vibeke
    Damjanov, Nemanja
    Scoville, Craig
    Tundia, Namita
    Camp, Heidi
    Chen, Kun
    Suboticki, Jessica L.
    van Vollenhoven, Ronald
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S54 - S54
  • [2] Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials
    Orbai, Ana-Maria
    Bingham, Clifton O., III
    CURRENT RHEUMATOLOGY REPORTS, 2015, 17 (04)
  • [3] Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials
    Ana-Maria Orbai
    Clifton O. Bingham
    Current Rheumatology Reports, 2015, 17
  • [4] Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab
    Andrea Rubbert-Roth
    Daniel E. Furst
    Stefano Fiore
    Amy Praestgaard
    Vivian Bykerk
    Clifton O. Bingham
    Christina Charles-Schoeman
    Gerd Burmester
    Arthritis Research & Therapy, 24
  • [5] Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab
    Rubbert-Roth, Andrea
    Furst, Daniel E.
    Fiore, Stefano
    Praestgaard, Amy
    Bykerk, Vivian
    Bingham, Clifton O.
    Charles-Schoeman, Christina
    Burmester, Gerd
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [6] Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis
    Massarotti, Elena M.
    CLINICAL THERAPEUTICS, 2008, 30 (03) : 429 - 442
  • [7] Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials
    Bingham, Clifton O.
    Bartlett, Susan J.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 70
  • [8] Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis
    Gossec, Laure
    Dougados, Maxime
    Dixon, William
    RMD OPEN, 2015, 1 (01):
  • [9] Association between MRI findings and patient-reported outcomes in patients with rheumatoid arthritis in clinical remission and at relapse
    Glinatsi, Daniel
    Brahe, Cecilie H.
    Hetland, Merete L.
    Ornbjerg, Lykke
    Krabbe, Simon
    Baker, Joshua F.
    Boesen, Mikael
    Rastiemadabadi, Zoreh
    Morsel-Carlsen, Lone
    Rogind, Henrik
    Hansen, Annette
    Norregaard, Jesper
    Jacobsen, Soren
    Terslev, Lene
    Huynh, Tuan K.
    Manilo, Natalia
    Jensen, Dorte, V
    Moller, Jakob M.
    Krogh, Niels S.
    Ostergaard, Mikkel
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (04) : 488 - 498
  • [10] Associations Between Rheumatoid Arthritis Disease Activity and Patient-reported Outcomes in Sarilumab Clinical Trials
    Burmester, Gerd
    Gossec, Laure
    van Hoogstraten, Hubert
    Praestgaard, Amy
    St John, Gregory
    Huizinga, Thomas
    Aletaha, Daniel
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345